New psoriasis cream shows promise in early trial
NCT ID NCT07546214
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study tested a cream called tapinarof on 575 adults with mild-to-moderate plaque psoriasis. The goal was to see if it safely clears skin patches better than a placebo cream. Participants applied the cream daily for several weeks, and doctors measured improvement in their psoriasis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Pharmaceutical Industries, Inc.
Hawthorne, New York, 10532, United States
Conditions
Explore the condition pages connected to this study.